Navigation Links
Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
Date:11/29/2011

o add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-looking Statements

This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, statements regarding the Company's expectations that data from the first Phase 3 trial of OMS302 will be available during the first quarter of 2012, that Omeros will initiate a second Phase 3 trial of OMS302 following discussions with regulators, that Omeros will be poised to file marketing applications as soon as possible following receipt of OMS302 Phase 3 clinical data , and that Omeros may have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2011. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... 22, 2013   Accuray Incorporated (Nasdaq: ... scheduled to present at the 2013 Jefferies Global Healthcare ... Thursday, June 6, 2013 at 1:30 p.m. EDT/10:30 a.m. ... will be available online from the Investor Relations page ... The webcast replay of the presentation will begin approximately ...
(Date:5/22/2013)... , May 22, 2013 JenaValve Technology, Inc., a ... implantation (TAVI) systems for the treatment of aortic valve disease, ... enaValve Eval U ation of Long Term P erformance ... E vere Ao R tic Stenosis (JUPITER) Registry at EuroPCR ... registry to evaluate five-year long term safety and effectiveness of ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4
... 5, 2011 Oncimmune ® LLC, maker of EarlyCDT™-Lung ... assessment and early detection of lung cancer , today announces ... test: audit of 1,000 patients in clinical practice" supports ... with sensitivity for non-small cell lung cancer (NSCLC) at least as ...
... D. Smith, the fourth largest national pharmaceutical wholesaler, announced ... Bruin as corporate vice president managed care.  De Bruin ... and managed care experience, his senior and strategic-level pharmacy ... new position at H. D. Smith, de Bruin will ...
Cached Medicine Technology:First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 2First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 3First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 4First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 5H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care 2
(Date:5/22/2013)... (PRWEB) May 22, 2013 Jury deliberations are ... trial involving a da Vinci lawsuit, Bernstein Liebhard ... family of a man who allegedly died of da Vinci ... $8 million in damages from Intuitive Surgical, Inc. Among ... training program for the da Vinci Surgical System in its ...
(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- Anyone ... is something about feet that fungi seem to like. ... the fungal groups that live on your skin -- ... It,s no secret that the human body is ... fungi, both outside and inside. And it,s mainly a ...
(Date:5/22/2013)... 2013 DePuy Pinnacle lawsuit ... Hip Replacement System continue to move forward in the ... LLP reports. According to an Order dated May ... monitoring reports associated with a 2007 criminal investigation by ... practices. Plaintiffs maintained in their December 2012 ...
(Date:5/22/2013)... UT (PRWEB) May 22, 2013 Today, ... Alabama Health Insurance Exchange . Zane Benefits, which ... health benefits, is the leader in defined contribution ... According to Zane Benefits’ website, beginning in 2014 as ... coverage for individuals and small businesses will become available ...
(Date:5/22/2013)... may be reaping enormous income for patients whose ... contracted in their intensive care units. , In ... American Journal of Medical Quality , the ... an avoidable central line-associated bloodstream infection (CLABSI) costs ... a similar infection-free patient. Moreover, hospitals earn nearly ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... study done by business advisory organization Grant Thornton International said ... Western counterparts. This is due to fewer holidays, business travel ... increase in the adrenalin rush among people in Taiwan, China ... owners in 30 countries, all of ,whom reported some rise ...
... dioxide emissions have rendered the oceans acidic, threatening the ... occurrence, akin to what happened to the dinosaurs, some ... the face of the earth. Ken Caldeira of the ... research at the AGU/ASLO Ocean Sciences meeting in Honolulu. ...
... that babies breastfed for six months have reduced respiratory ... was conducted by investigators at UC Davis Children's Hospital, ... Pediatrics, Center for Child Health Research. ,In ... Davis Children's Hospital, lead author, "We found that babies ...
... Chicago is doing a good job to facilitate paired donor ... after they registered with this organization.// ,A case of ... from their wives because of blood group mismatch, met at ... each other’s husbands. This has indeed given the husband’s a ...
... Melanoma, a form of skin cancer is the most common tumor ... early, say researchers from University Hospital of Navarra. // Sadly, the ... is the number one killer of women aged between 19 and ... risen from 6000 to 9000 in just 10 years. ...
... of a child, to determine the location and number of hemorrhages ... discussed in the American Academy of Forensic Sciences annual meeting held ... located behind the eye. Any rupture in the retinal surface can ... retinal hemorrhage. , A wide variety of conditions such ...
Cached Medicine News:Health News:New Technique Could Revolutionize Melanoma Diagnosis and Treatment 2Health News:Retinal Hemorrhage: No More a Sure Sign of Child Abuse 2
... multiple core biopsies of soft tissue. Lightweight ... facilitates one-handed control. Precise, rapid firing mechanism ... stylet permits easy penetration into the specimen ... cutting edge of cannula helps assure an ...
... the iQ®200 Automated Urine Microscopy Analyzer ... Automated Urine Chemistry Analyzer (AX-4280) to ... microscopic analysis. The iQ200 uses Auto-Particle ... network, to classify and quantitate twelve ...
... The Iris Diagnostics iQ®200 Automated ... imaging and Auto-Particle Recognition (APR®) software ... categories and quantitatively report results. The ... to prepare and interpret particle images ...
... Alpha has been designed as a compact, ... hospitals, offices, private clinics or as a ... and the most commonly required investigations such ... included. Add-on options are available for ...
Medicine Products: